BPC-157 (BPC)

Healing Preclinical

Body Protection Compound-157, a pentadecapeptide derived from human gastric juice that has shown remarkable healing properties across multiple tissue types.

Key Data

Research Status
Preclinical
Half-Life
4-6 hours
Administration
Subcutaneous injection
Typical Dosage
250-500 mcg

Mechanism of Action

Promotes angiogenesis, protects endothelium, increases growth factor expression including VEGF and EGF. Interacts with nitric oxide and dopamine systems.

Reported Benefits

All information is presented for Research Use Only (RUO). Not medical advice.

← All Peptides Dosing Calculator Community Forum Home